Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Imlifidase
Related studies linked through entity extraction aliases.
Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients
- Status
- WITHDRAWN
- Phase
- PHASE2
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)
- Status
- TERMINATED
- Phase
- PHASE1
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
- Status
- RECRUITING
- Phase
- PHASE2
A Study With Imlifidase in Anti-GBM Disease
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
- Status
- COMPLETED
- Phase
- PHASE3
An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
- Status
- TERMINATED
- Phase
- N/A
A Study of Imlifidase in Patients With Guillain-Barré Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
- Status
- COMPLETED
- Phase
- N/A
Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease
- Status
- COMPLETED
- Phase
- PHASE2